Versant Ventures Iv, Llc - Net Worth and Insider Trading

Versant Ventures Iv, Llc Net Worth

The estimated net worth of Versant Ventures Iv, Llc is at least $108 Million dollars as of 2024-04-24. Versant Ventures Iv, Llc is the 10% Owner of Audentes Therapeutics Inc and owns about 1,806,832 shares of Audentes Therapeutics Inc (BOLD) stock worth over $108 Million. Details can be seen in Versant Ventures Iv, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Versant Ventures Iv, Llc has not made any transactions after 2016-07-25 and currently still holds the listed stock(s).

Transaction Summary of Versant Ventures Iv, Llc

To

Versant Ventures Iv, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Versant Ventures Iv, Llc owns 8 companies in total, including IVERIC bio Inc (ISEE) , Inari Medical Inc (NARI) , and Oyster Point Pharma Inc (OYST) among others .

Click here to see the complete history of Versant Ventures Iv, Llc’s form 4 insider trades.

Insider Ownership Summary of Versant Ventures Iv, Llc

Ticker Comapny Transaction Date Type of Owner
ISEE IVERIC bio Inc 2018-10-30 10 percent owner
NARI Inari Medical Inc 2020-11-17 10 percent owner
OYST Oyster Point Pharma Inc 2019-10-30 10 percent owner
CRSP CRISPR Therapeutics AG 2018-04-20 10 percent owner
BOLD Audentes Therapeutics Inc 2016-07-25 10 percent owner
ADVM Adverum Biotechnologies Inc 2016-05-11 10 percent owner
CLVSQ Clovis Oncology Inc 2011-11-15 10 percent owner
TPST Tempest Therapeutics Inc 2022-04-29 10 percent owner

Versant Ventures Iv, Llc Latest Holdings Summary

Versant Ventures Iv, Llc currently owns a total of 1 stock. Versant Ventures Iv, Llc owns 1,806,832 shares of Audentes Therapeutics Inc (BOLD) as of July 25, 2016, with a value of $108 Million.

Latest Holdings of Versant Ventures Iv, Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BOLD Audentes Therapeutics Inc 2016-07-25 1,806,832 59.97 108,355,715

Holding Weightings of Versant Ventures Iv, Llc


Versant Ventures Iv, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Versant Ventures Iv, Llc has made a total of 0 transactions in Audentes Therapeutics Inc (BOLD) over the past 5 years. The most-recent trade in Audentes Therapeutics Inc is the acquisition of 35,000 shares on July 25, 2016, which cost Versant Ventures Iv, Llc around $525,000.

Insider Trading History of Versant Ventures Iv, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Versant Ventures Iv, Llc Trading Performance

GuruFocus tracks the stock performance after each of Versant Ventures Iv, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Versant Ventures Iv, Llc is 15.79%. GuruFocus also compares Versant Ventures Iv, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Versant Ventures Iv, Llc within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Versant Ventures Iv, Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Versant Ventures Iv, Llc

Average Return

48.52%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.42 15.79 2.55 48.52 61.19 37.37
Relative Return to S&P 500(%) 2.24 16.96 -3.44 34.29 46.63 25.9

Versant Ventures Iv, Llc Ownership Network

Ownership Network List of Versant Ventures Iv, Llc

No Data

Ownership Network Relation of Versant Ventures Iv, Llc


Versant Ventures Iv, Llc Owned Company Details

What does IVERIC bio Inc do?

Who are the key executives at IVERIC bio Inc?

Versant Ventures Iv, Llc is the 10 percent owner of IVERIC bio Inc. Other key executives at IVERIC bio Inc include SVP & COO Keith Westby , SVP & CFO and Treasurer David Francis Carroll , and Senior Vice President & CCO Christopher Paul Simms .

IVERIC bio Inc (ISEE) Insider Trades Summary

Over the past 18 months, Versant Ventures Iv, Llc made no insider transaction in IVERIC bio Inc (ISEE). Other recent insider transactions involving IVERIC bio Inc (ISEE) include a net sale of 316,820 shares made by Keith Westby , a net sale of 128,049 shares made by David Francis Carroll , and a net sale of 69,457 shares made by Glenn Sblendorio .

In summary, during the past 3 months, insiders sold 0 shares of IVERIC bio Inc (ISEE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 514,326 shares of IVERIC bio Inc (ISEE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 514,326 shares.

IVERIC bio Inc (ISEE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

IVERIC bio Inc Insider Transactions

No Available Data

Versant Ventures Iv, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Versant Ventures Iv, Llc. You might contact Versant Ventures Iv, Llc via mailing address: One Sansome Street, Suite 3630, San Francisco Ca 94104.

Discussions on Versant Ventures Iv, Llc

No discussions yet.